INVESTOR ALERT: Faruqi & Faruqi, LLP Announces Investigation of Orexigen Therapeutics and Encourages Investors Who Suffered Losses in Excess of $100,000 to Contact the Firm - OREX

News provided by

Mar 06, 2015, 05:16 ET

NEW YORK, March 6, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Orexigen Therapeutics, Inc. ("Orexigen" or the "Company") (NASDAQ: OREX).

The investigation focuses on whether the Company and its executives violated federal securities laws by making false and misleading statements and/or failing to disclose material facts regarding its business and operations.

On March 5, 2015, Forbes published a report quoting an FDA official who stated that the Company's recent interim study results regarding their Contrave drug are extremely unreliable.

On this news, shares of Orexigen fell $0.91 per share or over 11% from its previous closing price to close at $7.10 per share on March 6, 2015,

Request more information now by clicking here: www.faruqilaw.com/OREX. There is no cost or obligation to you.

Take Action

If you invested in Orexigen stock, bonds or options between November 25, 2013 and March 5, 2015 and would like to discuss your legal rights, visit www.faruqilaw.com/OREX. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Orexigen's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

SOURCE Faruqi & Faruqi, LLP